NFKB1 and neoplasm: Conversely, in models of breast, ovarian cancer and glioblastoma, canonical NF-κB activation in macrophages has an anti-inflammatory effect, preventing antitumor immunity and allowing tumor escape, in particular through the secretion of interleukin (IL)-10 [26,27,28,29].